Celldex Therapeutics Shares Down 44.6% Since SmarTrend's Sell Call (CLDX)
September 25, 2015 at 10:50 AM EDT
SmarTrend identified a Downtrend for Celldex Therapeutics (NASDAQ:CLDX) on July 27th, 2015 at $23.92. In approximately 2 months, Celldex Therapeutics has returned 44.60% as of today's recent price of...